
Stéphane Bancel
PersonHeard in 14 episodes across 9 shows since Jul 2026
Stéphane Bancel is a French businessman and the chief executive officer of the biotechnology company Moderna. He is known for his leadership in the pharmaceutical and biotechnology industries, particularly during the development of the Moderna COVID-19 vaccine.
Episodes
First heard
Guest appearances
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 1 |
| Aug 2026 | 4 |
| Sep 2026 | 2 |
| Oct 2026 | 5 |
| Nov 2026 | 2 |
Email alert
Email me when Stéphane Bancel comes up on a podcast
One email a week at most, with the new episodes that mention Stéphane Bancel. Free, no account needed, unsubscribe in one click.
What Stéphane Bancel has said on podcasts
9 statements
Moderna’s redesigned COVID vaccine has substantially improved side effects.
“the side effect is much better.”
Open the episode · NVIDIA Without Jensen, Anthropic IPO Risks & Moderna’s Cancer Vaccine 11/12/26Listen at 29:45
Moderna’s cancer vaccine is individually manufactured for each patient.
“We basically individualize. We make a product for one human at a time”
Open the episode · NVIDIA Without Jensen, Anthropic IPO Risks & Moderna’s Cancer Vaccine 11/12/26Listen at 31:32
The personalized vaccine is administered intramuscularly every three weeks for nine doses.
“It's injected in intramuscular every three weeks for nine doses.”
Open the episode · NVIDIA Without Jensen, Anthropic IPO Risks & Moderna’s Cancer Vaccine 11/12/26Listen at 31:43
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
14 episodes featuring Stéphane Bancel, newest first
- Nov 13, 2026
NVIDIA turmoil meets Anthropic’s IPO gamble and Moderna’s cancer betMad Money w/ Jim CramerNov 13, 2026Guest - Nov 4, 2026
McCullough challenges pandemic orthodoxy and institutional trustThe Joe Rogan ExperienceNov 4, 2026 - Oct 30, 2026
Amazon earnings test the AI spending boomHalftime ReportOct 30, 2026 - Oct 30, 2026
Cancer vaccine data meets market volatility at ESMOThe Readout LoudOct 30, 2026 - Oct 23, 2026
Moderna’s cancer data sparks a market frenzy and bigger questionsTBPNOct 23, 2026 - Oct 23, 2026
TBPN tests the limits of AI, fusion and engineered animalsTBPNOct 23, 2026